US 10934306
Hepatitis B antiviral agents
granted A61KA61K31/167A61K31/18
Quick answer
US patent 10934306 (Hepatitis B antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/167, A61K31/18, A61K31/196, A61K31/215